Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

US FDA refuses to approve Merck's Zetia and Vytorin medicines
US FDA refuses to approve Merck's Zetia and Vytorin medicines
                                   Zetiia                                                              VytorinThe US Food and Drug Administration (...
Biocon's Rosuvastatin Calcium tablets get EU approval to treat hyperlipidemia
Biocon's Rosuvastatin Calcium tablets get EU approval to treat hyperlipidemia
Indian biopharmaceutical company Biocon has received approval from the European Commission for its Rosuvastatin Calcium tablets to treat hyperlipidemia or mixed dyslipidemia.
Sun Pharma calls off Merck deal
Sun Pharma calls off Merck deal
Our Special Correspondent, Mumbai.
FDA grants orphan status for Amarantus' eltoprazine to treat PD-LID
FDA grants orphan status for Amarantus' eltoprazine to treat PD-LID
The US Food and Drug Administration (FDA) has granted orphan drug designation for Amarantus BioScience Holdings' (AMBS') eltoprazine to treat Parkinson's disease levodopa-i...
Glaxo fined £37.6m for 'illegal behaviour' over Seroxat deals
Glaxo fined £37.6m for 'illegal behaviour' over Seroxat deals
GlaxoSmithKline has been fined £37.
Teva Shares Plunge as Sales of Copaxone Disappoint
Teva Shares Plunge as Sales of Copaxone Disappoint
Teva Pharmaceutical Industries Ltd.
Nanoparticle reduces targeted cancer drug's toxicity
Nanoparticle reduces targeted cancer drug's toxicity
The polymeric nanoparticle Accurin encapsulates the clinical candidate AZD2811, an Aurora B kinase inhibitor.
Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%
Promius Pharma™ Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%
HYDERABAD, India & PRINCETON, N.
Mylan to buy Swedish drugmaker Meda in $7.2 billion deal
Mylan to buy Swedish drugmaker Meda in $7.2 billion deal
Generic drugmaker Mylan NV (MYL.
Medicare may experiment with caps to cancer-drug reimbursements
Medicare may experiment with caps to cancer-drug reimbursements
Look out, cancer drugmakers--the U.
FDA puts full clinical hold on CTI BioPharma's blood cancer drug
FDA puts full clinical hold on CTI BioPharma's blood cancer drug
Feb 9 (Reuters) - CTI BioPharma Corp said the U.
Pfizer Announces Leadership Team Upon Close of Allergan Deal
Pfizer Announces Leadership Team Upon Close of Allergan Deal
As previously announced, Brent Saunders will become president/CEO of the combined company with responsibility for Pfizer and Allergan’s combined commercial businesses, manufacturing and strategy fun...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand